Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about edit

Recent news which mentions edit

< Previous 1 2 3 4 5 6 7 8 9 Next >
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
Tickers BEAM CRSP EDIT NEWS
Tags Trading Ideas Health Care SHL
From Benzinga
Expert Outlook: Editas Medicine Through The Eyes Of 7 Analysts
Tickers EDIT
Tags Market News Benzinga Analyst Ratings
From Benzinga
Where Editas Medicine Stands With Analysts
Tickers EDIT
Tags Analyst Ratings BZI/AAR EDIT
From Benzinga
Looking for Stock Bargains With Room to Run? Try This.
Tickers AAPL AMZN BJRI CBRL
Tags AMZN AAPL DESP
From Motley Fool
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
Tickers BMBL BOOT CENTA CRL
Tags EDIT News CRL
From Benzinga
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
Tickers CRSP EDIT NTLA
Tags Stocks to Buy EDIT NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA
From InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
Tickers CRSP EDIT NTLA
Tags Market News NTLA CRSP
From InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Tickers CRSP EDIT GNOM ILMN
Tags NTLA ILMN CRSP
From InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Tickers CRSP EDIT NLTA
Tags CRSP NLTA Market News
From InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
Tickers CRSP EDIT NTLA
Tags EDIT Stocks to Buy Market News
From InvestorPlace
Unveiling 5 Analyst Insights On Editas Medicine
Tickers EDIT
Tags Market News Benzinga BZI/AAR
From Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
Tickers EDIT
Tags Benzinga Market News Analyst Ratings
From Benzinga
Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential
Tickers CNXC EDIT Z
Tags Z Uncategorized Market News
From InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
Tickers C EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
Tickers EDIT
Tags Market News NASDAQ:EDIT Earnings Reports
From InvestorPlace
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
Tickers EDIT
Tags EDIT Recent Press Releases Market News
From Motley Fool
1 Beaten-Down Stock With 55% Upside, According to Wall Street
Tickers EDIT
Tags EDIT Market News Recent Press Releases
From Motley Fool
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
Tickers C EDIT VRTX
Tags VRTX Market News Recent Press Releases
From Motley Fool
The Latest Analyst Ratings For Editas Medicine
Tickers EDIT
Tags Benzinga Market News EDIT
From Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Tickers AAP ACMR ADIL ADT
Tags OGEN LFST MSTR
From Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
Tickers AAP ACMR ADT ADY
Tags Intraday Update AGO Movers
From Benzinga
Earnings Outlook For Editas Medicine
Tickers EDIT
Tags EDIT BZI/EP Market News
From Benzinga
2 Under-the-Radar Stocks With Incredible Upside Potential
Tickers EDIT RXRX
Tags Market News Recent Press Releases RXRX
From Motley Fool
Could Editas Medicine Become the Next CRISPR Therapeutics?
Tickers CRSP EDIT
Tags Recent Press Releases Market News CRSP
From Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
Tickers ASXC EDIT HOLX ILMN
Tags Stocks to Buy EDIT ASXC
From InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
Tickers CRSP EDIT VRTX
Tags VRTX CRSP Recent Press Releases
From Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
Tickers BEAM EDIT LLY VERV
Tags Market News NASDAQ:EDIT,NASDAQ:VRTX,NASDAQ:BEAM,NASDAQ:VERV,NYSE:LLY BEAM
From InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
Tickers EDIT NTLA
Tags EDIT Recent Press Releases NTLA
From Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
Tickers EDIT VRTX
Tags VRTX Market News Recent Press Releases
From Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
Tickers EDIT SPX VRTX VTRS
Tags SPX VRTX EDIT
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.